Skip to content

The Effects of Metoprolol on the Cardiorespiratory Response to orotracheal extubation: prospective, randomized, double-blind, placebo-controlled clinical trial

The Effects of Metoprolol on the Hemodynamic and Respiratory response to orotraqueal extubation: prospective, randomized, double-blinded and placebo-controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-3xk4qkq
Enrollment
Unknown
Registered
2021-05-21
Start date
2021-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Phenomena

Interventions

The proposal is a prospective, randomized, double-blind study comparing the hemodynamic response to tracheal extubation in 226 patients undergoing placebo infusion (0.9% saline) or metoprolol, all sur
T1: at the end of surgery (reversal of neuromuscular block)
T2: Pre-infusion (one minute before the study drugs are infused)
T3: first minute of the infusion
T4: end of infusion
T5: during extubation
T6: one minute after extubation
T7: three minutes after extubation
T8: five minutes after extubation
T9: ten minutes after extubation
T10: aft
D27.505.519.625.050.200. 200

Sponsors

Hospital de Base do Distrito Federal
Lead Sponsor
Hospital de Base do Distrito Federal
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 60 years, scheduled to undergo surgery under general anesthesia. Physical status 1 2 and 3 of the American Society of Anesthesiology (ASA).

Exclusion criteria

Exclusion criteria: Patients with contraindications or a history of hypersensitivity to the drugs involved in the study. Patients with heart, lung, kidney, liver or neurological disease. Patients who refuse to participate.

Design outcomes

Primary

MeasureTime frame
We hope to find a reduction in the incidence of respiratory complications, such as coughing, bucking, bronchospasm or laryngospasm during tracheal extubation

Secondary

MeasureTime frame
We hope to find a reduction in the incidence of cardiovascular complications, such as tachycardia and hypertension during tracheal extubation.

Countries

Brazil

Contacts

Public ContactFabricio Mendonça
fabriciotmendonca@hotmail.com+556133151588

Outcome results

None listed

Source: REBEC (via WHO ICTRP)